Tue, October 27, 2020

Salim Syed Maintained (BIIB) at Hold with Decreased Target to $282 on, Oct 27th, 2020

Salim Syed of Mizuho, Maintained "Biogen Inc." (BIIB) at Hold with Decreased Target from $316 to $282 on, Oct 27th, 2020.

Salim has made no other calls on BIIB in the last 4 months.



There are 7 other peers that have a rating on BIIB. Out of the 7 peers that are also analyzing BIIB, 3 agree with Salim's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Laura Chico of "Wedbush" Maintained at Hold with Decreased Target to $244 on, Thursday, October 22nd, 2020
  • Christopher Raymond of "Piper Sandler" Maintained at Hold with Decreased Target to $265 on, Tuesday, October 20th, 2020
  • Brian Abrahams of "RBC Capital" Maintained at Hold with Decreased Target to $277 on, Friday, September 18th, 2020


These are the ratings of the 4 analyists that currently disagree with Salim


  • Evan Seigerman of "Credit Suisse" Maintained at Buy with Decreased Target to $350 on, Thursday, October 22nd, 2020
  • Matthew Harrison of "Morgan Stanley" Maintained at Buy with Increased Target to $357 on, Thursday, October 22nd, 2020
  • Geoff Meacham of "B of A Securities" Maintained at Sell with Decreased Target to $235 on, Thursday, October 15th, 2020
  • Marc Goodman of "SVB Leerink" Maintained at Buy with Decreased Target to $342 on, Wednesday, August 19th, 2020